Klappa

Public flashcard deck · 384 cards

Midterm 4 Final Review

Study this deck free Add to my library

  1. Front
    General transamination
    Back
    amino acid + α-ketoglutarate ⇌ α-keto acid + glutamate
  2. Front
    Usual amino group acceptor in transamination
    Back
    α-ketoglutarate
  3. Front
    Usual nitrogen-containing product of transamination
    Back
    Glutamate
  4. Front
    Transamination enzyme class
    Back
    Aminotransferases/transaminases
  5. Front
    Transamination coenzyme
    Back
    PLP, pyridoxal phosphate, a vitamin B6 derivative
  6. Front
    Reversibility of transamination
    Back
    Transamination reactions are reversible
  7. Front
    Role of transamination
    Back
    Used in both amino acid degradation and amino acid synthesis
  8. Front
    Most amino acids and transamination
    Back
    Most amino acids undergo transamination
  9. Front
    Classic amino acid exceptions to transamination
    Back
    Lysine and threonine
  10. Front
    ALT reaction
    Back
    alanine + α-ketoglutarate ⇌ pyruvate + glutamate
  11. Front
    ALT role in muscle
    Back
    Nitrogen from amino acid catabolism is collected into alanine
  12. Front
    Alanine transport role
    Back
    Alanine travels from muscle to liver carrying nitrogen
  13. Front
    ALT role in liver
    Back
    Alanine gives nitrogen back to glutamate and pyruvate can be used for gluconeogenesis
  14. Front
    Glucose-alanine cycle
    Back
    Nitrogen is transported from muscle to liver as alanine while pyruvate supports hepatic gluconeogenesis
  15. Front
    AST reaction
    Back
    glutamate + oxaloacetate ⇌ α-ketoglutarate + aspartate
  16. Front
    High-yield role of AST in liver
    Back
    Aspartate donates the second nitrogen of urea
  17. Front
    Metabolic connection made by AST
    Back
    AST connects amino acid metabolism, the Krebs cycle, and the urea cycle
  18. Front
    Major amino acid degradation route
    Back
    Transamination followed by glutamate deamination
  19. Front
    Vitamin required for transamination
    Back
    Vitamin B6 as PLP
  20. Front
    Oxidative deamination of glutamate reaction
    Back
    glutamate + NAD(P)+ + H2O ⇌ α-ketoglutarate + NH4+ + NAD(P)H + H+
  21. Front
    Oxidative deamination enzyme
    Back
    Glutamate dehydrogenase
  22. Front
    Oxidative deamination location
    Back
    Mitochondria
  23. Front
    Oxidative deamination reversibility
    Back
    Reversible
  24. Front
    Free ammonium release
    Back
    Glutamate dehydrogenase releases free NH4+
  25. Front
    Glutamate dehydrogenase cofactors
    Back
    NAD+ or NADP+
  26. Front
    Glutamate dehydrogenase activator
    Back
    ADP
  27. Front
    Glutamate dehydrogenase inhibitor
    Back
    GTP
  28. Front
    Central reaction in transdeamination
    Back
    Oxidative deamination of glutamate by glutamate dehydrogenase
  29. Front
    Most amino acid α-amino groups converted to ammonia by
    Back
    Transaminases followed by glutamate dehydrogenase
  30. Front
    Reason free ammonia is transported safely
    Back
    Free ammonia is toxic
  31. Front
    Main blood transport form of ammonia from most tissues
    Back
    Glutamine
  32. Front
    Main blood transport form of ammonia from muscle
    Back
    Alanine
  33. Front
    Glutamine synthetase reaction
    Back
    glutamate + NH4+ + ATP → glutamine + ADP + Pi
  34. Front
    Glutamine synthetase role
    Back
    Incorporates free ammonia into glutamine and detoxifies ammonia
  35. Front
    Glutamine as nitrogen transport
    Back
    Glutamine transports nitrogen safely in blood
  36. Front
    Glutamine in nucleotide synthesis
    Back
    Glutamine is a nitrogen donor in nucleotide synthesis
  37. Front
    Glutaminase reaction
    Back
    glutamine + H2O → glutamate + NH4+
  38. Front
    Glutaminase role in liver
    Back
    Provides NH4+ for urea synthesis
  39. Front
    Glutaminase role in kidney
    Back
    Provides NH4+ for urinary acid excretion
  40. Front
    Official ammonia transport topics
    Back
    Glutamine synthesis, glutaminase in liver and kidney, and ammonia transport by glutamine and alanine
  41. Front
    Urea cycle purpose
    Back
    Disposes of toxic ammonia as urea
  42. Front
    Urea cycle tissue
    Back
    Mainly liver
  43. Front
    Urea cycle compartmentation
    Back
    First steps occur in mitochondria and later steps occur in cytosol
  44. Front
    First nitrogen source of urea
    Back
    Free NH4+ enters as carbamoyl phosphate
  45. Front
    Second nitrogen source of urea
    Back
    Aspartate donates the second nitrogen
  46. Front
    CPS I reaction
    Back
    NH4+ + HCO3− + 2 ATP → carbamoyl phosphate + 2 ADP + Pi
  47. Front
    CPS I full name
    Back
    Carbamoyl phosphate synthetase I
  48. Front
    CPS I location
    Back
    Mitochondria
  49. Front
    CPS I activator
    Back
    N-acetylglutamate
  50. Front
    CPS I role
    Back
    Urea cycle
  51. Front
    Nitrogen entry into urea cycle
    Back
    Nitrogen enters as carbamoyl phosphate and aspartate
  52. Front
    Direct precursor of urea
    Back
    Arginine
  53. Front
    Urea cycle step 1
    Back
    CPS I converts NH4+ + HCO3− to carbamoyl phosphate
  54. Front
    Urea cycle step 2
    Back
    OTC converts ornithine + carbamoyl phosphate to citrulline
  55. Front
    Citrulline transport in urea cycle
    Back
    Citrulline exits the mitochondria
  56. Front
    Urea cycle step 3
    Back
    Argininosuccinate synthetase converts citrulline + aspartate + ATP to argininosuccinate
  57. Front
    Urea cycle step 4
    Back
    Argininosuccinate lyase converts argininosuccinate to arginine + fumarate
  58. Front
    Urea cycle step 5
    Back
    Arginase converts arginine to urea + ornithine
  59. Front
    Urea cycle connection to Krebs cycle
    Back
    Urea cycle produces fumarate
  60. Front
    Fumarate fate from urea cycle
    Back
    Fumarate → malate → oxaloacetate
  61. Front
    Aspartate regeneration for urea cycle
    Back
    Oxaloacetate + glutamate via AST → aspartate
  62. Front
    Most serious consequence of urea cycle failure
    Back
    Hyperammonemia
  63. Front
    CPS I pathway
    Back
    Urea cycle
  64. Front
    CPS II pathway
    Back
    Pyrimidine synthesis
  65. Front
    CPS I location
    Back
    Mitochondria
  66. Front
    CPS II location
    Back
    Cytosol
  67. Front
    CPS I tissue
    Back
    Liver
  68. Front
    CPS II tissue
    Back
    Many or all cells
  69. Front
    CPS I nitrogen donor
    Back
    NH4+
  70. Front
    CPS II nitrogen donor
    Back
    Glutamine amide nitrogen
  71. Front
    CPS I activator
    Back
    N-acetylglutamate
  72. Front
    CPS II activators
    Back
    PRPP and ATP
  73. Front
    CPS I inhibitor
    Back
    None emphasized
  74. Front
    CPS II inhibitor
    Back
    UTP
  75. Front
    CPS I versus CPS II high-yield distinction
    Back
    CPS I is mitochondrial, hepatic, uses NH4+, and functions in the urea cycle; CPS II is cytosolic, broadly expressed, uses glutamine, and functions in pyrimidine synthesis
  76. Front
    Only ketogenic amino acids
    Back
    Leucine and lysine
  77. Front
    Memory for only ketogenic amino acids
    Back
    Leu and Lys are lonely ketogenic
  78. Front
    Amino acids both glucogenic and ketogenic
    Back
    Isoleucine, phenylalanine, tyrosine, tryptophan, and threonine
  79. Front
    Glucogenic amino acids
    Back
    All amino acids except the only ketogenic amino acids and the amino acids that are both glucogenic and ketogenic
  80. Front
    Common past-test ketogenic amino acid answer
    Back
    Leucine
  81. Front
    Essential amino acid mnemonic
    Back
    PVT TIM HALL
  82. Front
    Phenylalanine essential status
    Back
    Essential amino acid
  83. Front
    Valine essential status
    Back
    Essential amino acid
  84. Front
    Threonine essential status
    Back
    Essential amino acid
  85. Front
    Tryptophan essential status
    Back
    Essential amino acid
  86. Front
    Isoleucine essential status
    Back
    Essential amino acid
  87. Front
    Methionine essential status
    Back
    Essential amino acid
  88. Front
    Histidine essential status
    Back
    Essential amino acid
  89. Front
    Arginine essential status
    Back
    Essential amino acid with conditional importance because synthesis may be insufficient in children or recovery
  90. Front
    Leucine essential status
    Back
    Essential amino acid
  91. Front
    Lysine essential status
    Back
    Essential amino acid
  92. Front
    Cysteine conditional nonessentiality
    Back
    Cysteine is nonessential only if methionine is supplied
  93. Front
    Tyrosine conditional nonessentiality
    Back
    Tyrosine is nonessential only if phenylalanine is supplied
  94. Front
    PLP identity
    Back
    PLP is pyridoxal phosphate, a vitamin B6 derivative
  95. Front
    PLP role in transamination
    Back
    PLP is required for transamination
  96. Front
    PLP role in amino acid decarboxylation
    Back
    PLP is required for amino acid decarboxylation
  97. Front
    PLP role in serine/threonine dehydratase
    Back
    PLP is required for serine/threonine dehydratase reactions
  98. Front
    PLP role in serine to glycine
    Back
    PLP is required for serine → glycine
  99. Front
    PLP role in cysteine synthesis
    Back
    PLP is required for cysteine synthesis from homocysteine + serine
  100. Front
    PLP role in heme synthesis
    Back
    PLP is required by ALA synthase
  101. Front
    PLP role in dopamine synthesis
    Back
    PLP is required for DOPA → dopamine
  102. Front
    PLP role in GABA synthesis
    Back
    PLP is required for glutamate → GABA
  103. Front
    PLP role in histamine synthesis
    Back
    PLP is required for histidine → histamine
  104. Front
    Phenylalanine to tyrosine cofactor trap
    Back
    Phenylalanine → tyrosine does not require PLP; it requires BH4
  105. Front
    Explicit PLP roles in outline
    Back
    Transamination, serine/threonine deamination, serine → glycine, and decarboxylations
  106. Front
    Serine synthesis precursor
    Back
    3-phosphoglycerate, a glycolysis intermediate
  107. Front
    Serine role in protein synthesis
    Back
    Serine is used for protein synthesis
  108. Front
    Serine as glycine precursor
    Back
    Serine is a precursor of glycine
  109. Front
    Serine as cysteine precursor
    Back
    Serine is a precursor of cysteine
  110. Front
    Serine in phospholipid synthesis
    Back
    Serine contributes to phospholipid synthesis
  111. Front
    Serine metabolic classification
    Back
    Glucogenic amino acid
  112. Front
    Serine to glycine reaction
    Back
    serine + THF ⇌ glycine + N5,N10-methylene-THF + H2O
  113. Front
    Serine to glycine enzyme
    Back
    Serine hydroxymethyltransferase
  114. Front
    Serine hydroxymethyltransferase coenzymes
    Back
    THF and PLP
  115. Front
    Major source of THF one-carbon groups
    Back
    Serine → glycine
  116. Front
    Glycine role in collagen/protein synthesis
    Back
    Glycine is needed for collagen and protein synthesis
  117. Front
    Glycine role in glutathione
    Back
    Glycine is needed for glutathione synthesis
  118. Front
    Glycine role in bile acids
    Back
    Glycine is needed for bile acids
  119. Front
    Glycine role in heme
    Back
    Glycine is needed for heme synthesis
  120. Front
    Glycine role in purines
    Back
    Glycine is needed for purine nucleotide synthesis
  121. Front
    Glycine role in creatine
    Back
    Glycine is needed for creatine synthesis
  122. Front
    Major non-dietary source of glycine
    Back
    Serine, requiring THF
  123. Front
    THF function
    Back
    Carries one-carbon units
  124. Front
    N5,N10-methylene-THF role
    Back
    dTMP synthesis
  125. Front
    N10-formyl-THF role
    Back
    Provides purine ring carbons C2 and C8
  126. Front
    N5-methyl-THF role
    Back
    Remethylation of homocysteine to methionine
  127. Front
    Folate deficiency effect on dTMP synthesis
    Back
    Impaired dTMP synthesis
  128. Front
    Folate deficiency effect on purine synthesis
    Back
    Impaired purine synthesis
  129. Front
    Folate deficiency effect on DNA synthesis
    Back
    Impaired DNA synthesis
  130. Front
    Folate deficiency effect on rapidly dividing cells
    Back
    Rapidly dividing cells are impaired
  131. Front
    Methotrexate target
    Back
    Dihydrofolate reductase
  132. Front
    Methotrexate effect on THF
    Back
    Prevents regeneration of THF
  133. Front
    Methotrexate effect on nucleotide synthesis
    Back
    Strongly slows dTMP, AMP, GMP, and IMP synthesis
  134. Front
    Methotrexate least direct nucleotide effect
    Back
    UMP synthesis is least directly affected because UMP synthesis does not need THF
  135. Front
    Explicit one-carbon metabolism outline topics
    Back
    THF, serine → glycine, folate effects on nucleotide synthesis, and B12/folate reactions
  136. Front
    SAM synthesis
    Back
    Methionine + ATP → S-adenosylmethionine/SAM
  137. Front
    SAM major role
    Back
    Major methyl donor
  138. Front
    SAM methylation example norepinephrine
    Back
    Norepinephrine → epinephrine
  139. Front
    SAM methylation example guanidinoacetate
    Back
    Guanidinoacetate → creatine
  140. Front
    SAM methylation example phosphatidylethanolamine
    Back
    Phosphatidylethanolamine → phosphatidylcholine/lecithin
  141. Front
    SAM methylation example N-acetylserotonin
    Back
    N-acetylserotonin → melatonin
  142. Front
    SAM methylation example nucleic acids
    Back
    DNA/RNA methylation
  143. Front
    SAM conversion after methyl donation
    Back
    SAM → S-adenosylhomocysteine → homocysteine
  144. Front
    Major fates of homocysteine
    Back
    Remethylation to methionine and transsulfuration to cysteine
  145. Front
    Homocysteine remethylation reaction
    Back
    homocysteine + N5-methyl-THF → methionine + THF
  146. Front
    Homocysteine remethylation requirements
    Back
    Vitamin B12 and N5-methyl-THF
  147. Front
    Homocysteine transsulfuration pathway
    Back
    Homocysteine + serine → cystathionine → cysteine
  148. Front
    Homocysteine transsulfuration requirement
    Back
    PLP/B6
  149. Front
    Carbon skeleton source for cysteine
    Back
    Serine
  150. Front
    Sulfur source for cysteine
    Back
    Methionine via homocysteine
  151. Front
    Cysteine conditional essentiality
    Back
    Cysteine is nonessential only if methionine is available
  152. Front
    B12-dependent homocysteine reaction
    Back
    Homocysteine → methionine
  153. Front
    B12-dependent methylmalonyl-CoA reaction
    Back
    Methylmalonyl-CoA → succinyl-CoA
  154. Front
    B12 deficiency effect on homocysteine
    Back
    Increased homocysteine
  155. Front
    B12 deficiency effect on methylmalonic acid
    Back
    Increased methylmalonic acid
  156. Front
    Folate deficiency effect on homocysteine
    Back
    Increased homocysteine
  157. Front
    Folate deficiency effect on methylmalonic acid
    Back
    Normal methylmalonic acid
  158. Front
    B12 versus folate deficiency distinction
    Back
    B12 deficiency increases homocysteine and methylmalonic acid; folate deficiency increases homocysteine with normal methylmalonic acid
  159. Front
    Amino acids producing propionyl-CoA
    Back
    Valine, isoleucine, methionine, and threonine
  160. Front
    Propionyl-CoA carboxylase reaction
    Back
    Propionyl-CoA → D-methylmalonyl-CoA
  161. Front
    Propionyl-CoA carboxylase cofactor
    Back
    Biotin
  162. Front
    Methylmalonyl-CoA racemase reaction
    Back
    D-methylmalonyl-CoA → L-methylmalonyl-CoA
  163. Front
    Methylmalonyl-CoA mutase reaction
    Back
    L-methylmalonyl-CoA → succinyl-CoA
  164. Front
    Methylmalonyl-CoA mutase cofactor
    Back
    B12
  165. Front
    Methylmalonic acidemia cause
    Back
    Defect in methylmalonyl-CoA mutase or B12 metabolism
  166. Front
    Phenylalanine to tyrosine reaction
    Back
    phenylalanine + O2 + BH4 → tyrosine + H2O + BH2
  167. Front
    Phenylalanine hydroxylase function
    Back
    Converts phenylalanine to tyrosine
  168. Front
    Phenylalanine hydroxylase cofactor
    Back
    Tetrahydrobiopterin/BH4
  169. Front
    Classical PKU defect
    Back
    Phenylalanine hydroxylase deficiency
  170. Front
    Classical PKU effect on phenylalanine
    Back
    Increased phenylalanine
  171. Front
    Classical PKU metabolites
    Back
    Increased phenylpyruvate, phenylacetate, and phenyllactate
  172. Front
    Tyrosine in classical PKU
    Back
    Tyrosine becomes essential
  173. Front
    Classical PKU treatment
    Back
    Low phenylalanine diet plus tyrosine
  174. Front
    Nonclassical hyperphenylalaninemia cause
    Back
    BH4 deficiency
  175. Front
    BH4 role in phenylalanine hydroxylase
    Back
    Required for phenylalanine hydroxylase
  176. Front
    BH4 role in tyrosine hydroxylase
    Back
    Required for tyrosine hydroxylase
  177. Front
    BH4 role in tryptophan hydroxylase
    Back
    Required for tryptophan hydroxylase
  178. Front
    BH4 role in nitric oxide synthase
    Back
    Required for nitric oxide synthase
  179. Front
    BH4 and transamination
    Back
    BH4 is not required for transamination
  180. Front
    Tyrosine to epinephrine pathway
    Back
    tyrosine → L-DOPA → dopamine → norepinephrine → epinephrine
  181. Front
    Tyrosine hydroxylase cofactor
    Back
    BH4
  182. Front
    DOPA decarboxylase cofactor
    Back
    PLP
  183. Front
    Dopamine β-hydroxylase cofactors
    Back
    Vitamin C and Cu
  184. Front
    PNMT cofactor
    Back
    SAM
  185. Front
    Tyrosine derivatives
    Back
    Catecholamines, melanin, and thyroid hormones
  186. Front
    Melanin synthesis enzyme
    Back
    Tyrosinase
  187. Front
    Tyrosinase cofactor
    Back
    Copper
  188. Front
    MSUD full name
    Back
    Maple syrup urine disease
  189. Front
    Amino acids affected in MSUD
    Back
    Leucine, isoleucine, and valine
  190. Front
    MSUD defective step
    Back
    Oxidative decarboxylation of branched-chain α-keto acids
  191. Front
    MSUD defective enzyme complex
    Back
    Branched-chain α-ketoacid dehydrogenase
  192. Front
    High-yield MSUD wording
    Back
    MSUD is inability to catabolize α-keto acids derived from valine, isoleucine, and leucine
  193. Front
    Glutamate derivatives
    Back
    GABA, glutathione, glutamine, proline, and arginine/ornithine family
  194. Front
    GABA synthesis reaction
    Back
    glutamate → GABA + CO2
  195. Front
    GABA synthesis enzyme
    Back
    Glutamate decarboxylase
  196. Front
    GABA synthesis cofactor
    Back
    PLP
  197. Front
    Histamine synthesis reaction
    Back
    histidine → histamine + CO2
  198. Front
    Histamine synthesis enzyme
    Back
    Histidine decarboxylase
  199. Front
    Histamine synthesis cofactor
    Back
    PLP
  200. Front
    Tryptophan to melatonin pathway
    Back
    Tryptophan → 5-hydroxytryptophan → serotonin → melatonin
  201. Front
    Tryptophan hydroxylase cofactor
    Back
    BH4
  202. Front
    5-HTP decarboxylase cofactor
    Back
    PLP
  203. Front
    Melatonin methylation cofactor
    Back
    SAM
  204. Front
    NOS reaction
    Back
    arginine + O2 + NADPH → citrulline + NO + NADP+
  205. Front
    NOS requirements
    Back
    Heme iron, FAD, FMN, BH4, and NADPH
  206. Front
    NO signaling
    Back
    NO activates guanylate cyclase → increased cGMP → smooth muscle relaxation
  207. Front
    Creatine precursors
    Back
    Arginine, glycine, and methionine/SAM methyl group
  208. Front
    Creatine synthesis in kidney
    Back
    Arginine + glycine → guanidinoacetate + ornithine
  209. Front
    Creatine synthesis in liver
    Back
    Guanidinoacetate + SAM → creatine
  210. Front
    Creatine in muscle
    Back
    Creatine ↔ creatine phosphate
  211. Front
    Creatinine excretion significance
    Back
    Reflects muscle mass and kidney function
  212. Front
    Heme metabolism high-yield topics
    Back
    Heme structure/role, heme synthesis, ALAS regulation, lead inhibition, porphyrias, heme oxygenase, bilirubin conjugation, jaundice patterns, and iron transport
  213. Front
    Main heme synthesis substrates
    Back
    Succinyl-CoA and glycine
  214. Front
    Highest heme synthesis activity
    Back
    Erythroid cells and liver
  215. Front
    Heme synthesis in mature erythrocytes
    Back
    Mature erythrocytes do not synthesize heme
  216. Front
    First and rate-limiting heme synthesis step
    Back
    succinyl-CoA + glycine → δ-aminolevulinate/ALA + CO2 + CoA
  217. Front
    ALA synthase function
    Back
    Catalyzes the first and rate-limiting step of heme synthesis
  218. Front
    ALA synthase cofactor
    Back
    PLP/B6
  219. Front
    ALA synthase location
    Back
    Mitochondria
  220. Front
    Major regulated step of heme synthesis
    Back
    ALA synthase reaction
  221. Front
    ALAS1 tissue
    Back
    Liver/nonerythroid isoform
  222. Front
    ALAS1 inhibitor
    Back
    Heme/hemin
  223. Front
    ALAS1 inducer
    Back
    Drugs that increase cytochrome P450 demand
  224. Front
    Fasting effect on porphyria
    Back
    Fasting or low-calorie states can worsen porphyria
  225. Front
    Glucose effect on hepatic ALAS1
    Back
    Glucose suppresses hepatic ALAS1
  226. Front
    ALAS2 tissue
    Back
    Erythroid isoform
  227. Front
    ALAS2 stimulation
    Back
    Stimulated by erythropoietin
  228. Front
    ALAS2 regulation
    Back
    Regulated by iron availability through IRE/IRP
  229. Front
    Heme and globin synthesis
    Back
    Heme coordinates globin synthesis
  230. Front
    Heme synthesis first sequence step
    Back
    Succinyl-CoA + glycine → ALA by ALA synthase with PLP in mitochondria
  231. Front
    Heme synthesis second sequence step
    Back
    2 ALA → porphobilinogen by ALA dehydratase/porphobilinogen synthase in cytosol
  232. Front
    ALA dehydratase inhibitor
    Back
    Lead
  233. Front
    Heme synthesis third sequence step
    Back
    4 porphobilinogen → hydroxymethylbilane by porphobilinogen deaminase/hydroxymethylbilane synthase
  234. Front
    Heme synthesis fourth sequence step
    Back
    Hydroxymethylbilane → uroporphyrinogen III by uroporphyrinogen III synthase
  235. Front
    Heme synthesis fifth sequence step
    Back
    Uroporphyrinogen III → coproporphyrinogen III by uroporphyrinogen decarboxylase
  236. Front
    Heme synthesis sixth sequence step
    Back
    Coproporphyrinogen III → protoporphyrinogen IX by coproporphyrinogen oxidase
  237. Front
    Heme synthesis seventh sequence step
    Back
    Protoporphyrinogen IX → protoporphyrin IX by protoporphyrinogen oxidase
  238. Front
    Heme synthesis final step
    Back
    Protoporphyrin IX + Fe2+ → heme by ferrochelatase
  239. Front
    Ferrochelatase inhibitor
    Back
    Lead
  240. Front
    Lead poisoning inhibited enzymes
    Back
    ALA dehydratase and ferrochelatase
  241. Front
    Porphyria general principle
    Back
    Enzyme block in heme synthesis causes upstream intermediates to accumulate
  242. Front
    Cause of photosensitivity in porphyrias
    Back
    Porphyrinogens/porphyrins cause photosensitivity because light exposure causes ROS formation
  243. Front
    Cause of neurovisceral symptoms in porphyrias
    Back
    ALA/PBG accumulation causes neurovisceral symptoms
  244. Front
    Acute intermittent porphyria defect
    Back
    Porphobilinogen deaminase/hydroxymethylbilane synthase
  245. Front
    Acute intermittent porphyria accumulation
    Back
    ALA and porphobilinogen
  246. Front
    Acute intermittent porphyria symptoms
    Back
    Abdominal pain, neuropsychiatric symptoms, constipation, and possible dark/red urine
  247. Front
    Acute intermittent porphyria photosensitivity
    Back
    No photosensitivity because accumulating compounds are precursors, not porphyrins
  248. Front
    Acute intermittent porphyria triggers
    Back
    P450-inducing drugs, barbiturates, alcohol, fasting/low-calorie diet, hormones, infection, and surgery
  249. Front
    Congenital erythropoietic porphyria defect
    Back
    Uroporphyrinogen III synthase
  250. Front
    Congenital erythropoietic porphyria inheritance
    Back
    Autosomal recessive
  251. Front
    Congenital erythropoietic porphyria accumulation
    Back
    Uroporphyrin I and coproporphyrin I
  252. Front
    Congenital erythropoietic porphyria symptoms
    Back
    Severe photosensitivity, red urine, erythrodontia, and hemolytic anemia
  253. Front
    Porphyria cutanea tarda defect
    Back
    Uroporphyrinogen decarboxylase
  254. Front
    Porphyria cutanea tarda frequency
    Back
    Most common porphyria
  255. Front
    Porphyria cutanea tarda features
    Back
    Photosensitivity/blistering, hepatic involvement, and red/brown urine
  256. Front
    Priority porphyrias for exam
    Back
    Acute intermittent porphyria, congenital erythropoietic porphyria, and porphyria cutanea tarda
  257. Front
    Heme oxygenase reaction
    Back
    heme + O2 + NADPH → biliverdin + Fe3+ + CO
  258. Front
    Heme oxygenase function
    Back
    Converts heme to biliverdin, Fe3+, and CO
  259. Front
    Biliverdin reductase reaction
    Back
    Biliverdin → bilirubin
  260. Front
    Unconjugated bilirubin solubility
    Back
    Water-insoluble and lipid-soluble
  261. Front
    Unconjugated bilirubin transport
    Back
    Transported in blood bound to albumin
  262. Front
    Bilirubin conjugation reaction
    Back
    bilirubin + 2 UDP-glucuronic acid → bilirubin diglucuronide
  263. Front
    Bilirubin conjugation enzyme
    Back
    UDP-glucuronosyltransferase
  264. Front
    Conjugated bilirubin identity
    Back
    Direct bilirubin
  265. Front
    Conjugated bilirubin solubility
    Back
    Water-soluble
  266. Front
    Conjugated bilirubin excretion
    Back
    Excreted in bile
  267. Front
    Intestinal bilirubin metabolism
    Back
    Bilirubin glucuronides enter intestine and bacteria convert them to urobilinogens
  268. Front
    Urobilinogen fate
    Back
    Some is reabsorbed, urinary urobilin is produced, and stool stercobilin is produced
  269. Front
    Hemolytic jaundice blood bilirubin
    Back
    Increased unconjugated bilirubin
  270. Front
    Hemolytic jaundice urine urobilinogen
    Back
    Increased urine urobilinogen
  271. Front
    Hemolytic jaundice feces
    Back
    Dark or normal feces with increased pigment
  272. Front
    Hepatocellular jaundice blood bilirubin
    Back
    Increased unconjugated and conjugated bilirubin
  273. Front
    Hepatocellular jaundice urine urobilinogen
    Back
    Increased urine urobilinogen
  274. Front
    Hepatocellular jaundice feces
    Back
    Pale/clay possible
  275. Front
    Obstructive/cholestatic jaundice blood bilirubin
    Back
    Increased conjugated bilirubin
  276. Front
    Obstructive/cholestatic jaundice urine urobilinogen
    Back
    Decreased or absent urine urobilinogen
  277. Front
    Obstructive/cholestatic jaundice feces
    Back
    Pale/clay feces
  278. Front
    Bile duct blockage bilirubin trap
    Back
    Conjugated bilirubin accumulates in blood because liver can conjugate bilirubin but bile cannot drain
  279. Front
    Newborn jaundice cause
    Back
    Low UDP-glucuronosyltransferase
  280. Front
    Newborn jaundice bilirubin pattern
    Back
    Increased unconjugated bilirubin
  281. Front
    Newborn jaundice major risk
    Back
    Kernicterus because unconjugated bilirubin can cross the blood-brain barrier
  282. Front
    Iron metabolism study focus
    Back
    Transport logic rather than obscure details
  283. Front
    Non-heme iron absorption
    Back
    Dietary Fe3+ is reduced to Fe2+
  284. Front
    Vitamin C effect on iron absorption
    Back
    Vitamin C helps non-heme iron reduction and absorption
  285. Front
    DMT1 function
    Back
    Fe2+ enters enterocyte via DMT1
  286. Front
    Heme iron absorption
    Back
    Heme iron is better absorbed and enters through a heme carrier pathway
  287. Front
    Iron release from heme in enterocyte
    Back
    Iron is released inside the enterocyte
  288. Front
    Intracellular iron storage
    Back
    Stored as ferritin
  289. Front
    Iron export from cells
    Back
    Fe2+ exits through ferroportin
  290. Front
    Hephaestin function
    Back
    Oxidizes Fe2+ to Fe3+ near enterocytes
  291. Front
    Ceruloplasmin function
    Back
    Oxidizes Fe2+ to Fe3+ in plasma/macrophage context
  292. Front
    Blood iron transport
    Back
    Fe3+ binds transferrin
  293. Front
    Hepcidin function
    Back
    Causes ferroportin degradation
  294. Front
    High hepcidin effect
    Back
    Decreased iron absorption and decreased iron release from macrophages
  295. Front
    Vitamin C iron absorption trap
    Back
    "Vitamin C inhibits iron absorption" is false; vitamin C helps non-heme iron absorption
  296. Front
    Nucleotide metabolism high-yield overview
    Back
    Purines are built on PRPP; IMP branches to AMP/GMP; pyrimidine ring comes from aspartate + carbamoyl phosphate; CTP comes from UTP + glutamine; RNR makes dNDPs; dTMP uses methylene-THF; salvage uses APRT/HGPRT; purine degradation ends in uric acid; allopurinol inhibits xanthine oxidase
  297. Front
    Purine de novo synthesis concept
    Back
    Purine ring is built on ribose
  298. Front
    PRPP synthesis reaction
    Back
    ribose-5-phosphate + ATP → PRPP
  299. Front
    PRPP synthetase function
    Back
    Converts ribose-5-phosphate to PRPP
  300. Front
    PRPP synthetase activator
    Back
    Pi
  301. Front
    PRPP synthetase inhibitor
    Back
    Purine ribonucleotides
  302. Front
    Committed step of purine synthesis
    Back
    PRPP + glutamine → 5-phosphoribosylamine + glutamate + PPi
  303. Front
    Committed purine synthesis enzyme
    Back
    Glutamine-PRPP amidotransferase
  304. Front
    Glutamine-PRPP amidotransferase activator
    Back
    PRPP
  305. Front
    Glutamine-PRPP amidotransferase inhibitors
    Back
    IMP, AMP, and GMP
  306. Front
    Purine ring N1 source
    Back
    Aspartate
  307. Front
    Purine ring N3 source
    Back
    Glutamine
  308. Front
    Purine ring N9 source
    Back
    Glutamine
  309. Front
    Purine ring C4 source
    Back
    Glycine
  310. Front
    Purine ring C5 source
    Back
    Glycine
  311. Front
    Purine ring N7 source
    Back
    Glycine
  312. Front
    Purine ring C6 source
    Back
    CO2/HCO3−
  313. Front
    Purine ring C2 source
    Back
    N10-formyl-THF
  314. Front
    Purine ring C8 source
    Back
    N10-formyl-THF
  315. Front
    Purine direct source trap
    Back
    N-methyl-THF or asparagine are not direct sources of purine ring atoms
  316. Front
    IMP role in purine synthesis
    Back
    Branch point for AMP and GMP synthesis
  317. Front
    IMP to AMP requirements
    Back
    Aspartate and GTP
  318. Front
    AMP synthesis fumarate production
    Back
    Fumarate is produced during the adenylosuccinate lyase step
  319. Front
    IMP to GMP requirements
    Back
    Glutamine, ATP, and NAD+ in the IMP dehydrogenase step
  320. Front
    Energy rule for AMP synthesis
    Back
    AMP synthesis uses GTP
  321. Front
    Energy rule for GMP synthesis
    Back
    GMP synthesis uses ATP
  322. Front
    Reciprocal energy balancing
    Back
    AMP synthesis uses GTP and GMP synthesis uses ATP
  323. Front
    Purine salvage purpose
    Back
    Saves energy
  324. Front
    Purine salvage tissue importance
    Back
    Important in brain and nonhepatic tissues
  325. Front
    Purine salvage ribose donor
    Back
    PRPP
  326. Front
    APRT reaction
    Back
    adenine + PRPP → AMP
  327. Front
    HGPRT hypoxanthine reaction
    Back
    hypoxanthine + PRPP → IMP
  328. Front
    HGPRT guanine reaction
    Back
    guanine + PRPP → GMP
  329. Front
    Lesch-Nyhan syndrome defect
    Back
    HGPRT deficiency
  330. Front
    Lesch-Nyhan syndrome features
    Back
    Hyperuricemia/gout, neurologic dysfunction, and self-mutilation
  331. Front
    HGPRT deficiency effect on purine synthesis
    Back
    Increased de novo purine synthesis because PRPP accumulates and salvage fails
  332. Front
    Conversion of hypoxanthine to IMP or guanine to GMP
    Back
    HGPRT
  333. Front
    Final product of purine degradation in humans
    Back
    Uric acid
  334. Front
    Important purine degradation enzymes
    Back
    Purine nucleoside phosphorylase, adenosine deaminase, and xanthine oxidase
  335. Front
    Xanthine oxidase reaction
    Back
    hypoxanthine → xanthine → uric acid
  336. Front
    Allopurinol target
    Back
    Xanthine oxidase
  337. Front
    Gout cause
    Back
    Hyperuricemia with sodium urate crystals
  338. Front
    Classic gout joint
    Back
    Big toe
  339. Front
    Adenosine deaminase deficiency
    Back
    Severe combined immunodeficiency pattern with decreased T cells, B cells, and antibodies
  340. Front
    Pyrimidine de novo synthesis concept
    Back
    Pyrimidine ring is built first, then attached to PRPP
  341. Front
    First step of pyrimidine synthesis
    Back
    glutamine + CO2 + 2 ATP → carbamoyl phosphate
  342. Front
    Pyrimidine first-step enzyme
    Back
    CPS II
  343. Front
    CPS II location
    Back
    Cytosol
  344. Front
    CPS II inhibitor
    Back
    UTP
  345. Front
    CPS II activators
    Back
    PRPP and ATP
  346. Front
    Pyrimidine ring aspartate contribution
    Back
    N1, C4, C5, and C6
  347. Front
    Pyrimidine ring carbamoyl phosphate contribution
    Back
    C2 and N3
  348. Front
    Ultimate source of pyrimidine N3
    Back
    Glutamine via CPS II
  349. Front
    Pyrimidine pathway first condensation
    Back
    Carbamoyl phosphate + aspartate → carbamoyl aspartate
  350. Front
    Pyrimidine pathway sequence
    Back
    Carbamoyl aspartate → dihydroorotate → orotate → OMP → UMP → UDP → UTP → CTP
  351. Front
    Orotate reaction
    Back
    Orotate + PRPP → OMP
  352. Front
    OMP reaction
    Back
    OMP → UMP
  353. Front
    UMP activation pathway
    Back
    UMP → UDP → UTP
  354. Front
    CTP synthesis reaction
    Back
    UTP + glutamine + ATP → CTP
  355. Front
    UTP to CTP enzyme
    Back
    CTP synthetase
  356. Front
    Direct precursor of CTP
    Back
    UTP
  357. Front
    Nitrogen donor for CTP synthesis
    Back
    Glutamine
  358. Front
    Ribonucleotide synthesis principle
    Back
    All ribonucleotides are first made as ribonucleotides
  359. Front
    Ribonucleotide reductase reaction
    Back
    NDP → dNDP
  360. Front
    Ribonucleotide reductase substrates
    Back
    ADP, GDP, CDP, and UDP
  361. Front
    Ribonucleotide reductase requirements
    Back
    Thioredoxin, NADPH, and ribonucleotide reductase
  362. Front
    Ribonucleotide reductase activator
    Back
    ATP
  363. Front
    Ribonucleotide reductase inhibitor
    Back
    dATP
  364. Front
    Ribonucleotide reductase substrate trap
    Back
    Substrate is NDP, not NMP or NTP
  365. Front
    dTMP synthesis reaction
    Back
    dUMP + N5,N10-methylene-THF → dTMP + DHF
  366. Front
    dTMP synthesis enzyme
    Back
    Thymidylate synthase
  367. Front
    Thymidylate synthase inhibitor
    Back
    5-fluorouracil converted to FdUMP
  368. Front
    THF regeneration reaction
    Back
    DHF → THF by dihydrofolate reductase
  369. Front
    Dihydrofolate reductase requirement
    Back
    NADPH
  370. Front
    Dihydrofolate reductase inhibitor
    Back
    Methotrexate
  371. Front
    Methotrexate consequence
    Back
    Blocks purine synthesis and dTMP synthesis
  372. Front
    5-FU consequence
    Back
    Directly blocks thymidylate synthase
  373. Front
    Folate deficiency nucleotide consequence
    Back
    Impairs DNA synthesis
  374. Front
    Xenobiotics/P450 study priority
    Back
    Not emphasized in the official outline but appeared in past questions enough to memorize a mini-block
  375. Front
    Cytochrome P450 identity
    Back
    Monooxygenase system
  376. Front
    Phase I metabolism
    Back
    Often introduces or exposes functional groups, often by hydroxylation
  377. Front
    Phase II metabolism
    Back
    Conjugation increases water solubility
  378. Front
    UDP-glucuronic acid role
    Back
    Used in glucuronidation
  379. Front
    Acetaminophen overdose toxic product
    Back
    NAPQI
  380. Front
    NAPQI detoxification
    Back
    Detoxified by glutathione
  381. Front
    Grapefruit juice effect
    Back
    Inhibits intestinal CYP3A4
  382. Front
    Grapefruit juice drug-level consequence
    Back
    Increases levels of some drugs such as statins
  383. Front
    Benzopyrene identity
    Back
    Polycyclic aromatic hydrocarbon activated by P450
  384. Front
    Benzopyrene detoxification
    Back
    Can involve glutathione conjugation

Study these 384 cards with spaced repetition. Klappa is a free flashcard app: it schedules every card with FSRS-6, studies a deck as flashcards, multiple choice, typed answers or a graded test, and imports your Anki decks. How Klappa schedules reviews.

Sign in to study